The aim of the study is to determine the prevalence of anal high-risk HPV infection and abnormal cytology in HIV uninfected Men who have sex with men (MSM) using PrEP and HIV infected MSM followed-up at the S-kliniek or HRC of the UZ Brussel. 200 participants will be preferably included in the study. The data will be collected using a self-administered questionnaire where socio-demographic characteristics, health-related issues and sexual behavior will be questioned. Also anal canal sampling will be performed for cytological analysis. For the HIV infected MSM, additional information will be extracted from the patient files: CD4+ T-cell count and nadir and duration of combination antiretroviral therapy.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
304
anal sampling will be performed both in men without HIV and men having HIV in order to see if they have HPV or not
Universitair ziekenhuis Brussel
Brussels, Belgium
To determine the prevalence of anal high risk HPV infection in MSM using PrEP
Time frame: 2 year
To compare the prevalence of high risk HPV in MSM using PrEP with that of HIV uninfected MSM not using PrEP
comparation will be done with partially using literature
Time frame: 2 year
To compare the prevalence of high risk HPV in MSM using PrEP with that of HIV infected MSM
Time frame: 2 year
to determine the prevalence of abnormal anal cytology in MSM using PrEP and in HIV infected MSM
Time frame: 2 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.